Discovery of IHMT-337 as a potent irreversible EZH2 inhibitor targeting CDK4 transcription for malignanciesHusheng Mei, Qingsong Liu, Bin Zhou et al.|Signal Transduction and Targeted Therapy|2023Cited by 46
Discovery of dihydropyridinone derivative as a covalent EZH2 degraderBin Zhou, Beilei Wang, Fengming Zou et al.|European Journal of Medicinal Chemistry|2023Cited by 11